Opportunity Information: Apply for RFA HL 10 004
Apply for RFA HL 10 004
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Childhood Obesity Prevention and Treatment Research Consortium (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837 Cardiovascular Diseases Research 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Feb 2, 2009 and posted on Feb 2, 2009.
- Applicants must submit their applications by Oct 6, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education State governments Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Childhood Obesity Prevention and Treatment Research Consortium (U01) (Funding Opportunity Number RFA HL 10 004) was a National Institutes of Health cooperative agreement funding opportunity led by the National Heart, Lung, and Blood Institute (NHLBI) in partnership with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Its central aim was to support rigorous randomized controlled trials that test innovative, practical intervention strategies directly relevant to the childhood obesity epidemic. Rather than funding basic observational work, the program was built to generate high-quality evidence about what works to prevent unhealthy weight gain and to improve weight-related outcomes among children and adolescents, with an eye toward reducing long-term cardiovascular and other chronic disease risks.
A defining feature of this opportunity is its focus on both prevention and treatment, with clear operational definitions. For this program, prevention includes two related goals: stopping excess weight gain in children who are not overweight (primary prevention) and preventing additional weight gain among youth who are already overweight or obese. Treatment, in contrast, is aimed at youth who are obese or severely obese and is defined as reducing weight, which can include actual weight loss or maintaining weight while a child grows taller (so that weight status improves as height increases). In practice, this means applicants were expected to propose trials with measurable outcomes related to body weight or adiposity and to tailor the intervention approach to the risk level of the population being studied.
The FOA targeted key developmental periods where interventions may have strong and lasting impact, specifically young children, pre-adolescents, and adolescents. It encouraged novel interventions, signaling interest in approaches that go beyond traditional, single-setting programs. While the announcement text does not prescribe specific intervention modalities, its emphasis on innovation and immediate relevance to the epidemic points toward multi-level strategies that could include family, school, health care, community, or policy-linked components, so long as they can be tested through randomized designs and produce interpretable results.
This award used the cooperative agreement mechanism (U01), which generally indicates a more active partnership between NIH and awardees than a standard research grant. The overall program was explicitly designed to promote collaboration and coordination across funded institutions, encourage exchange of scientific information, and build partnerships with local, state, and national agencies. The FOA also ran in parallel with a separate companion announcement seeking a Research Coordinating Unit (RFA HL 10 005). Together, these pieces were intended to function as a consortium, meaning that individual trial sites would not operate in isolation; instead, they would contribute to a coordinated research effort with shared goals, harmonized methods where appropriate, and cross-site learning intended to accelerate progress in the field.
The opportunity welcomed applications from multidisciplinary and transdisciplinary teams, including established networks as well as new collaborations formed specifically to conduct these trials. The intent was to bring together expertise needed to address childhood obesity as a complex, multi-factor problem, which typically spans clinical medicine, nutrition, physical activity science, behavioral and social science, biostatistics, health services research, and community engagement. High-quality trial design and execution were central expectations, given the programmatic emphasis on randomized controlled trials and on generating evidence capable of informing practice and policy.
Eligibility was broad and inclusive across many organization types. Eligible applicants included public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (other than small businesses), state governments, federally recognized tribal governments, and other tribal organizations. The FOA also explicitly included organizations such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. There was no cost sharing or matching requirement, which lowered barriers to participation for organizations that might not be able to contribute significant non-federal funds.
In terms of administrative details, the FOA was posted February 2, 2009, with an original and current closing date of October 6, 2009, and an archive date of November 6, 2009. It was categorized under discretionary funding, using the cooperative agreement instrument, and aligned with the health-related activity categories reflected in the CFDA numbers 93.837 (Cardiovascular Diseases Research) and 93.865 (Child Health and Human Development Extramural Research). The full announcement and related materials were hosted on the NIH grants site, with support contacts routed through the NIH Office of Extramural Research webmaster for access or linking issues.
Overall, the grant opportunity was structured to build a coordinated national research effort capable of producing actionable evidence on preventing excess weight gain and improving weight outcomes among children and teens. By emphasizing randomized trials, collaboration across sites, and partnerships with public agencies and communities, the program sought to speed translation from research to real-world approaches that could reduce obesity-related illness and premature mortality later in life, especially cardiovascular disease and other chronic conditions tied to childhood obesity.
Frequently Asked Questions (FAQs)
What is the Childhood Obesity Prevention and Treatment Research Consortium (U01)?
It was a National Institutes of Health (NIH) cooperative agreement funding opportunity (U01) called the Childhood Obesity Prevention and Treatment Research Consortium, listed as Funding Opportunity Number RFA HL 10 004. It was led by the National Heart, Lung, and Blood Institute (NHLBI) in partnership with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
What was the main purpose of this funding opportunity?
The central aim was to support rigorous randomized controlled trials (RCTs) that test innovative, practical intervention strategies directly relevant to the childhood obesity epidemic. The intent was to generate high-quality evidence about what works to prevent unhealthy weight gain and to improve weight-related outcomes among children and adolescents, with the longer-term goal of reducing cardiovascular and other chronic disease risks.
Was this opportunity focused on basic or observational research?
No. The program was designed to fund randomized controlled trials that produce actionable evidence. It was explicitly positioned as generating evidence about interventions rather than supporting basic observational work.
What types of studies were emphasized?
The program emphasized rigorous randomized controlled trials with measurable outcomes related to body weight or adiposity. Applicants were expected to propose interventions that could be tested through randomized designs and produce interpretable results.
How did the FOA define "prevention" for childhood obesity?
For this program, prevention included two goals: (1) stopping excess weight gain in children who are not overweight (primary prevention), and (2) preventing additional weight gain among youth who are already overweight or obese.
How did the FOA define "treatment" for childhood obesity?
Treatment was aimed at youth who are obese or severely obese and was defined as reducing weight. This could include actual weight loss or maintaining weight while the child grows taller, so that weight status improves as height increases.
Which age groups or developmental periods were targeted?
The FOA targeted key developmental periods where interventions may have strong and lasting impact: young children, pre-adolescents, and adolescents.
What kinds of intervention strategies were encouraged?
The FOA encouraged novel interventions and signaled interest in approaches that go beyond traditional, single-setting programs. While it did not prescribe specific modalities, it emphasized innovation and relevance to the epidemic and pointed toward multi-level strategies (for example, involving families, schools, health care, communities, or policy-linked components) as long as they could be tested in randomized designs.
What is the U01 cooperative agreement mechanism, and why does it matter?
U01 is a cooperative agreement mechanism, which generally indicates a more active partnership between NIH and awardees than a standard research grant. In this opportunity, the cooperative agreement structure supported collaboration, coordination across funded institutions, and exchange of scientific information.
Was this intended to operate as a consortium rather than isolated projects?
Yes. The FOA was explicitly designed to promote collaboration and coordination across funded institutions and to build partnerships with local, state, and national agencies. Individual trial sites were expected to contribute to a coordinated research effort with shared goals, harmonized methods where appropriate, and cross-site learning.
Was there a coordinating component associated with this program?
Yes. This FOA ran in parallel with a companion announcement seeking a Research Coordinating Unit (RFA HL 10 005). Together, these components were intended to function as a consortium.
What kinds of teams were encouraged to apply?
The opportunity welcomed multidisciplinary and transdisciplinary teams, including established networks and new collaborations formed specifically to conduct these trials. It encouraged bringing together the expertise needed to address childhood obesity as a complex, multi-factor problem.
What areas of expertise were considered relevant for applicant teams?
The FOA indicated childhood obesity typically spans multiple disciplines and highlighted areas such as clinical medicine, nutrition, physical activity science, behavioral and social science, biostatistics, health services research, and community engagement.
What types of organizations were eligible to apply?
Eligibility was broad and included public and private institutions of higher education; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); state governments; federally recognized tribal governments; and other tribal organizations.
Did the FOA explicitly welcome applications from specific institution types (for example, HBCUs or tribal colleges)?
Yes. The FOA explicitly included historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
Was cost sharing or matching required?
No. The FOA stated there was no cost sharing or matching requirement.
When was the FOA posted, and what were the key dates?
The FOA was posted on February 2, 2009. The original and current closing date was October 6, 2009, and the archive date was November 6, 2009.
Which NIH institutes led and partnered on this opportunity?
The opportunity was led by the National Heart, Lung, and Blood Institute (NHLBI) in partnership with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
What funding category and award instrument did this use?
It was categorized under discretionary funding and used the cooperative agreement instrument (U01).
Which CFDA numbers were associated with this opportunity?
The FOA aligned with CFDA 93.837 (Cardiovascular Diseases Research) and 93.865 (Child Health and Human Development Extramural Research).
Where were the full announcement and related materials hosted?
The full announcement and related materials were hosted on the NIH grants site.
Who was listed for support contacts related to access or linking issues?
Support contacts for access or linking issues were routed through the NIH Office of Extramural Research webmaster.
What was the broader public health goal behind funding these trials?
The program sought to speed translation from research to real-world approaches that could reduce obesity-related illness and premature mortality later in life, especially cardiovascular disease and other chronic conditions tied to childhood obesity.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Childhood Obesity Prevention and Treatment Research Coordinating Unit (U01)
Previous opportunity: Industrial Assessment Centers Technical Field Manager
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 10 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 10 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Childhood Obesity Prevention and Treatment Research Coordinating Unit (U01) Apply for RFA HL 10 005 Funding Number: RFA HL 10 005 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Outcomes Research in Orthotics and Prosthetics (R01) Apply for RFA HD 09 007 Funding Number: RFA HD 09 007 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $350,000 |
| Translational Research in Pediatric and Obstetric Pharmacology (R03) Apply for PAR 09 154 Funding Number: PAR 09 154 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology (R01) Apply for PAR 09 155 Funding Number: PAR 09 155 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Pediatric and Obstetric Pharmacology (R21) Apply for PAR 09 156 Funding Number: PAR 09 156 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $275,000 |
| Womens Reproductive Health Research (WRHR) Career Development Program (K12) Apply for RFA HD 09 026 Funding Number: RFA HD 09 026 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $440,000 |
| Considerations For The Safe and Effective Use of Iron Interventions In Context of Malaria and Its Co morbidities (U01) Apply for RFA HD 09 029 Funding Number: RFA HD 09 029 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Factors Affecting Cognitive Function in Adults with Down Syndrome (R01) Apply for RFA HD 09 028 Funding Number: RFA HD 09 028 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $500,000 |
| Noninvasive Assays of Human Oocytes and Preimplantation Embryos (STTR R41) Apply for RFA HD 09 024 Funding Number: RFA HD 09 024 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $100,000 |
| Noninvasive Assays of Human Oocytes and Preimplantation Embryos (SBIR R43) Apply for RFA HD 09 025 Funding Number: RFA HD 09 025 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $100,000 |
| Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54) Apply for RFA HD 09 027 Funding Number: RFA HD 09 027 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR R41) Apply for RFA HD 09 018 Funding Number: RFA HD 09 018 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| Advanced Tools and Technologies for Cerebrospinal Fluid Shunts STTR (R41/R42) Apply for PA 09 205 Funding Number: PA 09 205 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Advanced Tools and Technologies for Cerebrospinal Fluid Shunts SBIR (R43/R44) Apply for PA 09 206 Funding Number: PA 09 206 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Medical Rehabilitation Research Resource (R24) Apply for RFA HD 09 013 Funding Number: RFA HD 09 013 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Fertility Preservation Research Advancing Beyond Technology (R01) Apply for RFA HD 09 009 Funding Number: RFA HD 09 009 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $500,000 |
| Limited Competition Addressing Health Disparities in Maternal and Child Health through Community Based Participatory Research (R03) Apply for RFA HD 09 010 Funding Number: RFA HD 09 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $75,000 |
| Genetic and Genomic Analysis of Xenopus (R03) Apply for PAR 09 242 Funding Number: PAR 09 242 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Cooperative Research Partnerships to Promote Workforce Diversity in the Reproductive Sciences (U01) Apply for RFA HD 09 008 Funding Number: RFA HD 09 008 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $400,000 |
| Population Research Infrastructure Program (PRIP) FY10 (R24) Apply for RFA HD 09 004 Funding Number: RFA HD 09 004 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 10 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
